113 related articles for article (PubMed ID: 22466634)
1. How long can we leave patients with pulmonary arterial hypertension on oral drug monotreatment?
Ogawa A; Matsubara H
Circ J; 2012; 76(5):1089-90. PubMed ID: 22466634
[No Abstract] [Full Text] [Related]
2. "Out of the blue"-safety and efficacy of pulmonary hypertension treatment in childhood*.
Kraemer U; Wildschuth E; Tibboel D
Pediatr Crit Care Med; 2014 May; 15(4):377-8. PubMed ID: 24801422
[No Abstract] [Full Text] [Related]
3. Impact of first-line sildenafil monotreatment for pulmonary arterial hypertension.
Yanagisawa R; Kataoka M; Taguchi H; Kawakami T; Tamura Y; Fukuda K; Yoshino H; Satoh T
Circ J; 2012; 76(5):1245-52. PubMed ID: 22333215
[TBL] [Abstract][Full Text] [Related]
4. [Oral sildenafil for pulmonary hypertension in neonates].
Gutiérrez Nicolás F; Viña Romero MM; González Carretero P; Merino Alonso J
Farm Hosp; 2011; 35(3):157-8. PubMed ID: 21439880
[No Abstract] [Full Text] [Related]
5. eComment. Further study needed.
Quraishi NN; Lemon TI; Black LF
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):968. PubMed ID: 24243943
[No Abstract] [Full Text] [Related]
6. Paediatric pulmonary hypertension and sildenafil: current practice and controversies.
Wardle AJ; Tulloh RM
Arch Dis Child Educ Pract Ed; 2013 Aug; 98(4):141-7. PubMed ID: 23771819
[TBL] [Abstract][Full Text] [Related]
7. Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?
Correale M; Montrone D; Ieva R; Di Biase M; Brunetti ND
Clin Res Cardiol; 2013 May; 102(5):391-3. PubMed ID: 23389056
[No Abstract] [Full Text] [Related]
8. Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure.
El Midany AA; Mostafa EA; Azab S; Hassan GA
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):963-8. PubMed ID: 23985411
[TBL] [Abstract][Full Text] [Related]
9. A new START for Sildenafil in pediatric pulmonary hypertension: reframing the dose-survival relationship in the STARTS-2 trial.
McElhinney DB
Circulation; 2014 May; 129(19):1905-8. PubMed ID: 24637560
[No Abstract] [Full Text] [Related]
10. Reply: To PMID 24837446.
Chen H; Weng Z
Urology; 2014 Jul; 84(1):56. PubMed ID: 24837448
[No Abstract] [Full Text] [Related]
11. Editorial comment.
Hanno P
Urology; 2014 Jul; 84(1):56. PubMed ID: 24837446
[No Abstract] [Full Text] [Related]
12. Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.
Vachiery JL; Huez S; Gillies H; Layton G; Hayashi N; Gao X; Naeije R
Br J Clin Pharmacol; 2011 Feb; 71(2):289-92. PubMed ID: 21219411
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological treatment of pulmonary hypertension at a turning point].
Watanabe H
Nihon Yakurigaku Zasshi; 2014 Apr; 143(4):165-72. PubMed ID: 24717603
[No Abstract] [Full Text] [Related]
14. Safety of sildenafil in infants*.
Samiee-Zafarghandy S; Smith PB; van den Anker JN
Pediatr Crit Care Med; 2014 May; 15(4):362-8. PubMed ID: 24583505
[TBL] [Abstract][Full Text] [Related]
15. [The prescription].
Rabe J
MMW Fortschr Med; 2013 Jan; 155(1):28. PubMed ID: 23573716
[No Abstract] [Full Text] [Related]
16. The beneficial impact of fasudil and sildenafil on monocrotaline-induced pulmonary hypertension in rats: a hemodynamic and biochemical study.
Jasińska-Stroschein M; Owczarek J; Łuczak A; Orszulak-Michalak D
Pharmacology; 2013; 91(3-4):178-84. PubMed ID: 23428587
[TBL] [Abstract][Full Text] [Related]
17. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
Barst RJ; Beghetti M; Pulido T; Layton G; Konourina I; Zhang M; Ivy DD;
Circulation; 2014 May; 129(19):1914-23. PubMed ID: 24637559
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease.
Humpl T; Reyes JT; Erickson S; Armano R; Holtby H; Adatia I
Cardiol Young; 2011 Apr; 21(2):187-93. PubMed ID: 21138617
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension in heart failure with preserved ejection fraction: a target for therapy?
Waxman AB
Circulation; 2011 Jul; 124(2):133-5. PubMed ID: 21747065
[No Abstract] [Full Text] [Related]
20. Inhaled iloprost plus oral sildenafil in patients with severe pulmonary arterial hypertension delays the need for lung transplantation.
Lopez-Meseguer M; Berastegui C; Monforte V; Bravo C; Domingo E; Roman A
Transplant Proc; 2013; 45(6):2347-50. PubMed ID: 23953548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
